El sueño del mercado de carbono: millones de créditos de carbonos por sumideros basados en el uso de la tierra

Los comerciantes de carbono y los estados parte emisores de alto nivel, les gustaría que todos los usos del suelo fuesen fuentes de compensación,  para retrazar y reducir las emisiones y de esa manera  hacer dinero con los mercados de carbono. Hay más de una ruta a este objetivo: REDD + + podría ser una manera, y el MDL en el sector UTS es otro, como veremos más adelante. Los estados partes también puede ser habilitadas para usar todos los mecanismos actuales y futuras de mercado para cumplir con sus compromisos de reducción. Este informe proporciona antecedentes de estas cuestiones claves para Cancún.

Genetically Engineered Trees: No Solution to Global Warming

Genetically engineered trees do not offer a solution to global warming, rather they are a global distraction from finding real solutions to the problems of global warming. In addition, they threaten the world’s forests through gene flow and other hazards. This is why people on all continents are raising the call for a global moratorium on the release of genetically modified trees into the environment.

Genetic Dialectic

The processes through which genetically engineered trees are being developed are profoundly biased against social arrangements which promote and rely on biological diversity. These processes are also riven by dilemmas and destructive tendencies which chains of technical refinements, no matter how long, are likely to be powerless to overcome. Tackling the challenge GM trees pose means tackling the industrial and bureaucratic tradition which seeks the radical simplification of landscapes. That entails alliance-building with groups working against or outside that tradition, from seed savers to communities battling encroachment of industrial tree farms on their land. In these respects, the issues raised by GM trees are similar to those raised by GM crops. Yet in many ways, genetic modification in forestry is an even more serious issue than genetic engineering in agriculture. Trees’ long lives and largely undomesticated status, their poorly understood biology and lifecycles, the complexity and fragility of forest ecosystems, and corporate and state control over enormous areas of forest land on which GM trees could be planted combine to create risks which are unique. The biosafety and social implications of the application of genetic engineering to forestry are grave enough to warrant both an immediate halt to releases of GM trees and renewed attention to the social, historical and political roots of the tree biotech boom.

The carbon market dream: millions of offsets from land-use “sinks”

Carbon traders and high emitting Parties would like all land-use to count as carbon sinks to offset sources, delay reducing emissions and make money for carbon markets. There is more than one route to this goal: REDD++ could be one way, and CDM in LULUCF is another, as we shall see. Parties could also be enabled to use every current and future market-based mechanism to meet their reduction commitments. This briefing provides background to these key issues for Cancun.

Carbon markets – A distraction from the real priority: immediate emission reductions

In discussions about climate, market interests are of course focused on finance and how the market can participate. In this context, market interests include not just carbon markets, but also land and commodity markets, mining, timber and paper, that hope to profit from offsets. There is a real risk that their increased participation could give market mechanisms, traders and investors more power over development and also over land than developing countries and their peoples.

Genetic Engineering in Plants and the “New Breeding Techniques (NBTs)”

Over the last 5-10 years there have been rapid developments in genetic engineering techniques (genetic modification). Along with these has come the increasing ability to make deeper and more complex changes in the genetic makeup and metabolic pathways of living organisms. This has led to the emergence of two new fields of genetic engineering that overlap with each other: synthetic biology and the so-called New Breeding Techniques (NBTs).

Why 'marginal' land does not solve the biofuel problems

Partly in order to respond to accusations that agrofuels compete with food production, some propose that agrofuel crops should only be planted on marginal or idle land. We are told there are millions of hectares of such land around the world. But before considering what could be grown on it we must define "marginal land". So-called marginal land may be a vital resource to local communities - especially women - to herders, pastoralists and to biodiversity.

Golden Rice, Patents and Vitamin A Deficiency

‘Golden Rice’ first caught the headlines in 2000. Genetically engineered with 3 genes from daffodils and bacteria, this GM rice has been designed to produce pro-vitamin A. Claimed by GM proponents and biotech industry as the answer to vitamin A deficiency (VAD), others see it as a diversion from relatively low-cost, but effective, initiatives, which can help people to achieve a better diet almost immediately. Furthermore, the experience of Southern farmers is that intensive rice production with the use of high chemical inputs ended their integrated farming systems. Such systems included other food sources such as fish, snails, water fowl and green leafy vegetables to provide a wide range of essential nutrients including (pro)vitamin A. ‘Golden Rice’ has still not been tested for environmental or food safety nor assessed for socio-economic impacts.

Argentina and GM soya

Soya is not bringing wealth to Argentina. "We are being occupied by the seed multinationals that have patented life and are forcing us to pay tribute to them," says Jorge Eduardo Rulli, one of Argentina’s leading agronomists. "The more we produce the poorer we become."

Patenting Genes

Three examples show that patents on genes and gene fragments seriously threaten future medical research. They can stifle research and collaboration and increase prices through patent monopolies, neither of which serve the public interest. A review of gene patents - both granted and pending over the last few years - is long overdue. In particular, the case of the CCR5 gene and AIDS clearly highlights the folly of granting broad patents for all medical applications. The simplest solution is for genes and gene fragments to be made unpatentable – political action is needed now before the companies clean up on gene patents and society is left counting the cost.


Subscribe to Briefing